TRIUMPH OF THERAPEUTIC - USES OF FAITH AFTER FREUD - RIEFF,P

被引：0
|
作者：
BERGEN, BJ [1 ]
机构：
[1] DARTMOUTH COLL, SCH MED, HANOVER, NH USA
来源：
AMERICAN SOCIOLOGICAL REVIEW | 1966年 / 31卷 / 06期
关键词：
D O I：
10.2307/2091708
中图分类号：
C91 [社会学];
学科分类号：
030301 ; 1204 ;
摘要：
引用
收藏
页码：896 / 897
页数：2
相关论文
共 50 条
  • [41] Rationale and design of the LosmApimod To Inhibit p38 MAP kinase as a TherapeUtic target and moDify outcomes after an acute coronary syndromE trial
    O'Donoghue, Michelle L.
    Glaser, Ruchira
    Aylward, Philip E.
    Cavender, Matthew A.
    Crisp, Adam
    Fox, Keith A. A.
    Laws, Ian
    Lopez-Sendon, Jose L.
    Steg, P. Gabriel
    Theroux, Pierre
    Sabatine, Marc S.
    Morrow, David A.
    AMERICAN HEART JOURNAL, 2015, 169 (05) : 622 - U60
  • [42] Distinct Outcomes of Oropharyngeal Squamous Cell Carcinoma Patients after Distant Failure According to p16 Status: Implication in Therapeutic Options
    Modesto, Anouchka
    Siegfried, Aurore
    Lusque, Amelie
    Vergez, Sebastien
    Sarini, Jerome
    Brouchet, Laurent
    Uro-Coste, Emmanuelle
    Graff-Cailleaud, Pierre
    Delord, Jean Pierre
    CURRENT ONCOLOGY, 2021, 28 (03) : 1673 - 1680
  • [43] p16 gene deletion and its methylation in gastric malt lymphoma patients: Correlation with therapeutic response after eradication for H. pylori
    Oda, I
    Doi, T
    Ono, H
    Hayashi, S
    Saito, D
    Endo, H
    Nishina, T
    Hirasaki, S
    GASTROENTEROLOGY, 2002, 122 (04) : A172 - A172
  • [44] MAPK p38-dependent foam cell formation of myeloid cells after pro-angiogenic induction as a risk factor of therapeutic angiogenesis
    Rohde, E.
    Schallmoser, K.
    Reinisch, A.
    Hofmann, N. A.
    Pfeifer, T.
    Rechberger, G.
    Lanzer, G.
    Linkesch, W.
    Kratky, D.
    Strunk, D.
    BONE MARROW TRANSPLANTATION, 2010, 45 : S283 - S283
  • [45] After interleukin-12p4O, are interleukin-23 and interleukin-17 the next therapeutic targets for inflammatory bowel disease?
    Zhang, Zili
    Hinrichs, David J.
    Lu, Huiying
    Chen, Hong
    Zhong, Wenwei
    Kolls, Jay K.
    INTERNATIONAL IMMUNOPHARMACOLOGY, 2007, 7 (04) : 409 - 416
  • [46] Antiplatelet efficacy of P2Y12 inhibitors (prasugrel, ticagrelor, clopidogrel) in patients treated by therapeutic hypothermia after cardiac arrest for acute myocardial infarction
    Bednar, F.
    Motovska, Z.
    Knot, J.
    Ulman, J.
    Marinov, I.
    Widimsky, P.
    EUROPEAN HEART JOURNAL, 2014, 35 : 348 - 348
  • [47] P084: Analysis of therapeutic efficacies of amodiaquine-arstesunate and artemether-lumefantrine for treatment of uncomplicated falciparum malaria in Burkina Faso five years after their implementation
    FW Nikiema
    I Zongo
    F Some
    J-B Ouedraogo
    L Penali
    Antimicrobial Resistance and Infection Control, 2 (Suppl 1)
  • [48] Analysis of histological therapeutic effect, apoptosis rate and p53 status after combined treatment with radiation, hyperthermia and 5-fluorouracil suppositories for advanced rectal cancers
    C Sakakura
    K Koide
    D Ichikawa
    T Wakasa
    M Shirasu
    A Kimura
    H Taniguchi
    A Hagiwara
    T Yamaguchi
    J Inazawa
    T Abe
    T Takahashi
    E Otsuji
    British Journal of Cancer, 1998, 77 : 159 - 166
  • [49] Delayed-type hypersensitivity responses to HIV Gag p24 relate to clinical outcome after peptide-based therapeutic immunization for chronic HIV infection
    Kran, Anne-Marte B.
    Sommerfelt, Maja A.
    Baksaas, Ingebjorg
    Sorensen, Birger
    Kvale, Dag
    APMIS, 2012, 120 (03) : 204 - 209
  • [50] Therapeutic effect of biodegradable 32P-chromic phosphate-poly(l-lactide) seeds on human hepatocellular carcinoma in nude mice after intratumoral implantation
    Shao, Guo Qiang
    Wang, Zi-Zheng
    Wang, Feng
    Li, Shao-hua
    Meng, Qing-le
    JOURNAL OF NUCLEAR MEDICINE, 2010, 51
12345